[1] 中华预防医学会.中国百日咳行动计划专家共识[J].中国疫苗和免疫,2021,27(3):317-327.
[2] 潘殊男,盛玉博.中国百日咳疫苗的现状及研发趋势初探[J].微生物学免疫学进展,2012,40(5):72-77.
[3] Lambert LC.Pertussis vaccine trials in the 1990s[J].J Infect Dis,2014,209(Sup 1):S4-S9.
[4] Decker MD,Edwards KM.Pertussis (whooping cough)[J].J Infect Dis,2021,224(Sup 4):S310-S320.
[5] 王华庆,安志杰,尹遵栋.国家免疫规划七种针对传染病70年防控成就回顾[J].中国疫苗和免疫,2019,25(4):359-367.
[6] 骆鹏,马霄.百日咳和百日咳疫苗的现状与挑战[J].中国疫苗和免疫,2019,25(3):334-339.
[7] 唐旻瑶. 青少年及成人用百白破疫苗在百日咳疾病预防中的应用[J].微生物学免疫学进展,2019,47(6):66-69.
[8] 胡业勤,段凯,李新国,等.组分无细胞百日咳疫苗纯化新工艺的建立[J].中国新药杂志,2018,27(21):2498-2504.
[9] Sheridan SL,Frith K,Snelling TL,et al.Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine:Recent epidemiology[J].Expert Rev Vaccines,2014,13(9):1081-1106.
[10] Gilberto S,Gerardo L,Cesar M,et al.Pertussis in Mexico from 2000 to 2019:A real-world study of incidence,vaccination coverage,and vaccine effectiveness[J]. Vaccine,2023,41(41):6105-6111.
[11] Mack I,Erlanger T,Lang P,et al.Dose-dependent effectiveness of acellular pertussis vaccine in infants:A population-based case-control study[J].Vaccine,2020,38(6):1444-1449.
[12] Belchior E,Guillot S,Poujol I,et al.Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis,France,2013[J].Med Mal Infect,2020,50(7):617-619.
[13] Caulfield AD,Callender M,Harvill ET.Generating enhanced mucosal immunity against Bordetella pertussis:Current challenges and new directions[J].Front Immunol,2023,14:1126107.
[14] Luis S,Camille L.The role of mucosal immunity in pertussis[J].Front Immunol,2018,9:3068.
[15] Keech C,Miller VE,Rizzardi B,et al.Immunogenicity and safety of BPZE1,an intranasal live attenuated pertussis vaccine,versus tetanus-diphtheria-acellular pertussis vaccine:A randomised,double-blind,phase 2b trial[J].Lancet,2023,401(10379):843-855.
[16] 世界卫生组织.免疫覆盖[EB/OL].(2023-07-18)[2024-02-20]. https://www.who.int/zh/news-room/fact-sheets/detail/immunization-coverage.
[17] WHO.Pertussis vaccines:WHO position paper,August 2015-Recommendations[J]. Vaccine,2016,34(12):1423-1425.
[18] Thierry-Carstensen B,Jordan K,Uhlving HH,et al.A randomized,double-blind,non-inferiority clinical trial on the safety and immunogenicity of a tetanus,diphtheria and monocomponent acellular pertussis (Tdap) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults[J].Vaccine,2012,30(37):5464-5471.
[19] Pingali C,Yankey D,Elam-Evans LD,et al.National,regional,state,and selected local area vaccination coverage among adolescents aged 13-17 Years-United States,2020[J]. MMWR Morb Mortal Wkly Rep,2021,70(35):1184-1190.
[20] Suryadevara M,Domachowske JB.Prevention of pertussis through adult vaccination[J]. Hum Vaccin Immunother,2015,11(7):1744-1747.
[21] Venkatesan P.US approval of Tdap vaccine specifically in pregnancy[J].Lancet Infect Dis,2022,22(12):1671.
[22] Razzaghi H,Kahn EK,Black LC,et al.Influenza and Tdap vaccination coverage among pregnant women-United States,April 2020[J].MMWR,2020,69(39):1391-1397.
[23] Ditosto JD,Weiss RE,Yee LM,et al.Association of Tdap vaccine guidelines with vaccine uptake during pregnancy[J].PLoS One,2021,16(7):e0254863.
[24] Murthy N,Wodi PA,McNally VV,et al.Advisory Committee on Immunization Practices Recommended Immunization Schedule for adults aged 19 years or older-United States,2024[J].MMWR,2024,73(1):11-15.
[25] Plotkin S.Plotkin's vaccines[M].Philadelphia:Elsevier,2018:729-730.
[26] Nicola V,Giusy V,Maria A,et al.Multidimensional frailty and vaccinations in older people:A cross-sectional study[J].Vaccines,2022,10(4):555.
[27] Dyda A,McIntyre P,Karki S,et al.Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program[J].Vaccine,2018,36(29):4157-4160.
[28] O’Halloran CA,Lu PJ,Meyer AS,et al.Tdap vaccination among healthcare personnel-21 states,2013[J].Am J Prev Med,2018,54(1):119-123.
[29] Barbosa SRC,Yin LW,Isabel MMD,et al.Pertussis antibodies and vaccination coverage among healthcare professionals in Brazil is inadequate:A cross-sectional serological study[J].Vaccine,2023,41(39):5769-5774.
[30] 国家卫生健康委员会.国家免疫规划疫苗儿童免疫程序及说明(2021年版)[J].中国病毒病杂志,2021,11(4):241-245. |
